Methazolamide

Zileuton is an NSAID, and  Anti Asthama agent.

Biophore's Zileuton:   USFDA approved manufacturing facility, DMF Number 26446, Completeness Assessment of the US DMF Complete.

Diazoxide is an Anti hypoglycemic agent.

Eliglustat is an Endocrine-Metabolic Agent is indicated for the Long-term treatment of adult patients with Gaucher disease type 1.

Biophore's Eliglustat: Under development

Gadobenate dimeglumine is an Diagnostic Agent which is indicated for the  treatment of Magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults.


Biophore's Gadobenate dimeglumine: API Developed, Stringent control on inorganic impurities, ...

Gadobutrol is an MRI Contrast Agent.

Biophore's Gadobutrol:  Product meets the specifications of the EP draft monograph,  All impurities below 0.05, Stringent control on sodium and chloride. 

Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.

Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed

Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.


Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016.

Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2. 

Sincalide is an Diagnostic Agent indicated To stimulate gallbladder, pancreatic secretion, to accelerate the transit of a barium meal through the small bowel.


Biophore's Sincalide: API Developed, Validations Planned in Q3 2016, DMF to be filed in Q1 2017.

Zofenopril is an Antihypertensive agent.

Biophore's Zofenopril: USFDA approved manufacturing facility, US DMF Filed  [ # 026446 ].

Tipiracil is an Thymidine  phosphorylase inhibitor/nucleoside metabolic inhibitor used to treatment of metastatic colorectal cancer.

Trifluridine is an Antiviral agent indicated for the treatment of of primary kerato conjunctivitis and recurrent epithelial keratitis.

Biophore India Pharmaceuticals Pvt Ltd. at CPHI BCN 2023